SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-08-006623
Filing Date
2008-06-05
Accepted
2008-06-05 17:15:48
Documents
4
Period of Report
2008-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y60068e8vk.htm 8-K 22083
2 EX-10.1: EMPLOYMENT AGREEMENT y60068exv10w1.htm EX-10.1 64087
3 EX-10.2: AMENDMENT TO EMPLOYMENT AGREEMENT y60068exv10w2.htm EX-10.2 4322
4 EX-99.1: PRESS RELEASE y60068exv99w1.htm EX-99.1 5134
  Complete submission text file 0000950123-08-006623.txt   97347
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Filer) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32949 | Film No.: 08883792
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1